Connors Technology has completed approximately $200 million in Series C funding.

Recently, the high-end surgical robot company Shenzhen Conascent Technology Co., Ltd. completed a C+ round of financing of about $200 million. This round of financing was jointly invested by Hongtou Company, Qiming Venture Capital, Daohe Investment, Gao Rong Venture Capital, and Xianfeng K2VC. Conascent Technology was established in 2019 and is mainly engaged in the development, manufacturing, and sales of high-end surgical robots. It has built a comprehensive underlying technology platform for surgical robots, with a production factory of over 10,000 square meters in the Greater Bay Area. Its independently developed Sentire Conascent endoscopic surgical robot has been approved by the NMPA for listing and continues to promote global medical device certifications. The company previously received investment from EQT in the C round, and Qiming Venture Capital participated in the B round and B+ round.